Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin

Circulation

Volumn 112, Issue 13, 2005, Pages 2031-2039

  Gill, Varinder ^a   Doig, Christopher ^a   Knight, Derrice ^a   Love, Emma ^a   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Endothelium; Immunoglobulin; Ischemia; Leukocytes; Reperfusion

Indexed keywords

BETA2 INTEGRIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; HISTAMINE; IMMUNOGLOBULIN; P SELECTIN GLYCOPROTEIN LIGAND 1; P SELECTIN GLYCOPROTEIN LIGAND 1 ANTIBODY; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CAT; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; IMMUNOPATHOLOGY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE ADHERENCE; MICROSCOPIC ANATOMY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; REPERFUSION; RISK BENEFIT ANALYSIS; VASCULAR DISEASE;

ANIMALS; ANTIGENS, CD18; CATS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; E-SELECTIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTE ROLLING; LEUKOCYTES; P-SELECTIN; REPERFUSION INJURY; VASCULAR DISEASES;

EID: 25444525221     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.546150     Document Type: Article

References (30)

1. Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmunity and inflammatory diseases. J Allergy Clin Immunol. 1997;100:151-157.
2. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med. 1992;326:107-116.
3. Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci. 2003;24(suppl 4):S217-S221.
4. Crow AR, Song S, Freedman J, Helgason CD, Humphries RK, Siminovitch KA, Lazarus AH. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood. 2003;102:558-560.
5. Alejandria MM, Lansang MA, Dans LF, Mantaring JBV. Intravenous immunoglobulin for treating sepsis and septic shock. In: The Cochrane Database of Systematic Reviews. 2002, Issue 1, Art. No. CD001090.
6. Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. In: The Cochrane Database of Systematic Reviews. 2003, Issue 4. Art. No. CD004000.
7. Mok GC, Sung RY, Yam MC, Arifi AA, Lam WW, Fok TF. A child with Kawasaki disease who survived after rupture of a coronary artery aneurysm. Eur J Pediatr. 2003;162:634-636.
8. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation. 2003;108:325-330.
9. Tse SM, Silverman ED, McCrindle BW, Yeung RS. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr. 2002;140:450-455.
10. Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Heart J. 2000:139(pt 1):217-223.
11. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol. 1995;57:523-528.
12. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest. 1996;98:1699-1702.
13. Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation. 1997;96:2302-2310.
14. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest. 1995;95:2510-2519.
15. Ibbotson GC, Doig C, Kaur J, Gill V, Ostrovsky L, Fairhead T, Kubes P. Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat Med. 2001;7:465-470.
16. Reinhardt PH, Kubes P. Differential leukocyte recruitment from whole blood via endothelial adhesion molecules under shear conditions. Blood. 1998;92:4691-4699.
17. Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol. 1991;115:223-234.
18. Levy JB, Pusey CD. Nephrotoxicity of intravenous immunoglobulin. Q J Med. 2000;93:751-755.
19. Bleeker WK, Teeling JL, Hack CE. Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood. 2001; 98:3136-3142.
20. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ Res. 1995;76:30-39.
21. Gaboury JP, Niu X-F, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 1996;93:318-326.
22. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol. 1987;253:H699-H703.
23. Oliver MG, Specian RC, Perry MA, Granger DN. Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation. 1991;15:331-346.
24. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res. 1994;74:336-343.
25. Jonas E, Dwenger A, Jonas M. Chemiluminescence response and adherence of neutrophils to cultured endothelial cells: influence of immunoglobulin G. J Biolumin Chemilumin. 1995;10:169-173.
26. Rigal D, Vermot-Desroches C, Heitz S, Bernaud J, Alfonsi F, Monier JC. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clin Immunol Immunopathol. 1994;71:309-314.
27. Ito Y, Lukita-Atmadja W, Machen NW, Baker GL, McCuskey RS. Effect of intravenous immunoglobulin G on the TNFalpha-mediated hepatic microvascular inflammatory response. Shock. 1999;11:291-295.
28. Kanwar S, Kubes P. Ischemia/reperfusion-induced granulocyte influx is a multistep process mediated by mast cells. Microcirculation. 1994;1: 175-182.
29. Kanwar S, Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol. 1994;267(pt 1):G316-G321.
30. Asa D, Raycroft L, Ma L, Aeed PA, Kaytes PS, Elhammer AP, Geng JG. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem. 1995;270: 11662-11670.